Sven Bostyn's Suggested readings

1- Patenting DNA Sequences (Polynucleotides) and Scope of Protection in the European Union: An Evaluation, Luxemburg, European Communities 2004, +146 pp.;

2- Enabling Biotechnological Inventions in Europe and the United States. A study of the patentability of proteins and DNA sequences with special emphasis on the disclosure requirement, Eposcript Series, nr. 4, EPO, München, 2001, +/- 340 pp;

3- The Patentability of Genetic Information Carriers, The new E.U. Directive 98/44 on the legal protection of biotechnological inventions, Intellectual Property Quarterly, 1999/1, 1-36;

4- One Patent a Day keeps the Doctor Away? Patenting Human Genetic Information and Health Care, 7 European Journal of Health Law, 2000/3, 229-264;

5- A European Perspective on the Ideal Scope of Protection and the Disclosure Requirement for Biotechnological Inventions in a Harmonised Patent System; The Quest for the Holy Grail?, 5 Journal of World Intellectual Property, 2002, 1013-1046;

6- A Test too Far? A Critical Analysis of the (Non)-Patentability of Diagnostic Methods and Consequences for BRCA1 Gene Type Patents in Europe, 5 Bio-Science Law Review, [2001/2002] 4, 111-121;

7- The Prodigal Son: The Relationship Between Patent Law and Health Care, 11 Medical Law Review, 2003, 67-120;

8- ‘The unbearable heaviness of harmonization: SPLT and CP’, p. 105-153, in M. Ricolfi (ed.), I brevetti per invenzione fra diritto europeo e diritto nazionale, Scritti di diritto industriale, Milano: Giuffrè 2004, +160 pp.;